TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
4/5/24 21:32 | 4/3/24 | VERA | Vera Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Grant Sean | CA | O | CFO | M.d | 1,484 | 14.87 | 0 | 100 | 71 | M | |||||||||||||||
4/5/24 21:32 | 4/3/24 | VERA | Vera Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Grant Sean | CA | O | CFO | S.d | -4,690 | 39.58 | 0 | -118 | -62 | 71 | M | ||||||||||||||
6/23/23 16:05 | 6/23/23 | VERA | Vera Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Grant Sean | CA | O | CFO | P | 83 | 16.60 | 0 | 5 | 9 | 60 | I | ||||||||||||||
2/17/23 16:17 | 2/6/23 | VERA | Vera Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Grant Sean | CA | O | CFO | P.a | 100 | 7.00 | 0 | 14 | 40 | 50 | D | ||||||||||||||
2/8/23 16:04 | 2/6/22 | VERA | Vera Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Grant Sean | CA | O | CFO | P | 100 | 7.00 | 0 | 14 | 35 | 55 | D | ||||||||||||||
6/16/22 16:06 | 6/15/22 | VERA | Vera Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Grant Sean | CA | O | CFO | P | 68 | 13.60 | 0 | 5 | 329 | 7 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |